Provided by Tiger Fintech (Singapore) Pte. Ltd.

ACADIA Pharmaceuticals

22.37
-0.3300-1.45%
Post-market: 22.370.00000.00%16:39 EST
Volume:1.82M
Turnover:40.37M
Market Cap:3.77B
PE:16.87
High:22.78
Open:22.50
Low:21.87
Close:22.70
52wk High:26.65
52wk Low:13.40
Shares:168.71M
Float Shares:115.85M
Volume Ratio:1.10
T/O Rate:1.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.33
EPS(LYR):1.37
ROE:33.18%
ROA:5.27%
PB:4.59
PE(LYR):16.37

Loading ...

Oct 13, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 08, 2022

Major Issues Report

8-K - Current report
Jun 10, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2022

Major Issues Report

8-K - Current report
Apr 08, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 21, 2021

Major Issues Report

8-K - Current report
Dec 14, 2021

Major Issues Report

8-K - Current report
Nov 23, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 05, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Oct 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 02, 2021

Major Issues Report

ACADIA PHARMACEUTICALS INC